Skip to main content
. 2017 Autumn;8(4):239–249. doi: 10.22088/cjim.8.4.239

Figure 6.

Figure 6

The the standardized mean difference for the mean serum ferritin (A) and average daily deferoxamine use (B) in Iranian thalassemia major patients treated with deferoxamine. Fixed effects model